Skip to the page

Data / Drug companies / Strychnos nux-vomica seed

Strychnos nux-vomica seed: 3 companies and 15 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Strychnos nux-vomica seed is listed in the FDA National Drug Code Directory by 3 companies, with 15 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are pellet; liquid, and the newest product started marketing on December 17, 2024.

The request: Get every company that lists strychnos nux-vomica seed in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
3
Products
15
Generic (ANDA) products
0 (0.0%)
Application numbers
0
Routes
Oral, Sublingual
Brand names
Nux Vomica, Nux Vomica, Nux Vomica 30X
openFDA record search
api.fda.gov

Companies that list strychnos nux-vomica seed

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Boiron13pelletUnapproved homeopathic productsJanuary 1, 2012
Sevene USA1pelletUnapproved homeopathic productsNovember 30, 2011
True Botanica, LLC1liquidUnapproved homeopathic productsDecember 17, 2024

Dosage forms

Dosage formProductsShare
Pellet1493.3%
Liquid16.7%

Marketing categories

Marketing categoryProductsShare
Unapproved homeopathic products15100%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.